# A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART

> **NCT00503061** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1000 (actual)

## Conditions studied

- Bronchial Asthma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00503061
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2010-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00503061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00503061, "A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00503061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*